ERYTECH strengthens its intellectual property position with the issuance of United States patent for erythrocytes containing arginine deiminase Post author:admERY Post published:September 23, 2015 Post category:Newsroom ERYTECH announces the issuance of a new patent in the United States. You Might Also Like ERYTECH Presents TRYbeCA-1 Trial-in-Progress Poster at the 2019 ASCO GI Annual Meeting January 18, 2019 ERYTECH Reports First Half of 2018 Financial Results and Provides Business Update September 10, 2018 ERYTECH Appoints Allene M. Diaz to its Board of Directors September 5, 2016
ERYTECH Presents TRYbeCA-1 Trial-in-Progress Poster at the 2019 ASCO GI Annual Meeting January 18, 2019
